• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肺移植]

[Lung transplantation].

作者信息

Sommerwerck U, Rabis T, Fleimisch P, Carstens H, Teschler H, Kamler M

机构信息

Abt. f. Pneumologie, Ruhrlandklinik, Westdeutsches Lungenzentrum, Universitätsklinikum Essen, Universität Duisburg-Essen, Tüschener Weg 40, 45239, Essen, Deutschland,

出版信息

Herz. 2014 Feb;39(1):74-83. doi: 10.1007/s00059-013-4044-3.

DOI:10.1007/s00059-013-4044-3
PMID:24477632
Abstract

Lung transplantation is a therapeutic option for patients with end-stage lung diseases. Selection of candidates requires careful consideration of the disease-specific indications and contraindications for transplantation. Advances have been made in candidate selection via the ability to prognosticate outcomes of various lung diseases and through the implementation of the lung allocation score (LAS) with specific consideration of the degree of urgency and good postoperative survival rate, after neglecting the waiting time. This system has resulted in decreased mortality on the waiting list for lung transplantation. The availability of donor organs can possibly be increased by implementation of ex vivo lung perfusion as an alternative to conventional organ preservation. Risk factors for poor outcomes post-lung transplantation have been identified and understanding of the physiological, cellular and molecular mechanisms responsible for lung and airway damage has been extensively expanded. Primary graft dysfunction, infectious diseases, acute rejection, antibody-mediated rejection, lymphocytic bronchiolitis, obliterative bronchiolitis, restrictive allograft syndrome, and chronic lung allograft dysfunction are well defined complications and continue to be common causes of morbidity and mortality. This article provides a comprehensive update on these topics for the non-transplantation clinician.

摘要

肺移植是终末期肺部疾病患者的一种治疗选择。候选者的选择需要仔细考虑移植的疾病特异性适应症和禁忌症。通过预测各种肺部疾病的预后能力以及实施肺分配评分(LAS),在忽略等待时间的情况下特别考虑紧急程度和良好的术后生存率,候选者选择方面取得了进展。该系统降低了肺移植等待名单上的死亡率。作为传统器官保存的替代方法,实施体外肺灌注可能会增加供体器官的可用性。已经确定了肺移植后不良结局的危险因素,并且对导致肺和气道损伤的生理、细胞和分子机制的理解有了广泛扩展。原发性移植功能障碍、传染病、急性排斥反应、抗体介导的排斥反应、淋巴细胞性细支气管炎、闭塞性细支气管炎、限制性同种异体移植综合征和慢性肺同种异体移植功能障碍是明确的并发症,仍然是发病和死亡的常见原因。本文为非移植临床医生提供了关于这些主题的全面更新。

相似文献

1
[Lung transplantation].[肺移植]
Herz. 2014 Feb;39(1):74-83. doi: 10.1007/s00059-013-4044-3.
2
Lung transplantation: a treatment option in end-stage lung disease.肺移植:终末期肺病的治疗选择。
Dtsch Arztebl Int. 2014 Feb 14;111(7):107-16. doi: 10.3238/arztebl.2014.0107.
3
Contemporary lung transplantation: the UCLA experience.当代肺移植:加州大学洛杉矶分校的经验
Clin Transpl. 2008:163-70.
4
[Lung transplantation. Possibilities and limitations].[肺移植。可能性与局限性]
Internist (Berl). 2004 Nov;45(11):1246-59. doi: 10.1007/s00108-004-1292-6.
5
General overview of lung transplantation and review of organ allocation.肺移植概述及器官分配综述
Proc Am Thorac Soc. 2009 Jan 15;6(1):13-9. doi: 10.1513/pats.200807-072GO.
6
High lung allocation score is associated with increased morbidity and mortality following transplantation.高肺分配评分与移植后发病率和死亡率的增加有关。
Chest. 2010 Mar;137(3):651-7. doi: 10.1378/chest.09-0319. Epub 2009 Oct 9.
7
Lung transplantation in the Lung Allocation Score era: Medium-term analysis from a single center.肺移植在肺分配评分时代:来自单个中心的中期分析。
Clin Transplant. 2018 Aug;32(8):e13298. doi: 10.1111/ctr.13298. Epub 2018 Jun 15.
8
Pulmonary complications of lung transplantation.肺移植的肺部并发症。
Chest. 2011 Feb;139(2):402-411. doi: 10.1378/chest.10-1048.
9
Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.定量胸部 CT 对慢性肺移植功能障碍进行分型及其与生存的关系。
Clin Transplant. 2018 May;32(5):e13233. doi: 10.1111/ctr.13233. Epub 2018 Apr 10.
10
Overview of clinical lung transplantation.临床肺移植概述。
Cold Spring Harb Perspect Med. 2014 Jan 1;4(1):a015628. doi: 10.1101/cshperspect.a015628.

本文引用的文献

1
The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Pediatric Lung and Heart-Lung Transplantation Report--2013; focus theme: age.国际心肺移植协会注册处:第十六份官方小儿肺与心肺移植报告——2013年;重点主题:年龄
J Heart Lung Transplant. 2013 Oct;32(10):989-97. doi: 10.1016/j.healun.2013.08.008.
2
Tumor regression and sirolimus-based therapy in lung transplantation.
J Heart Lung Transplant. 2013 Sep;32(9):938-9. doi: 10.1016/j.healun.2013.06.022.
3
Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).中性粒细胞可逆性移植肾失功(NRAD)和限制型移植肾综合征(RAS)。
Semin Respir Crit Care Med. 2013 Jun;34(3):352-60. doi: 10.1055/s-0033-1348463. Epub 2013 Jul 2.
4
Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.闭塞性细支气管炎综合征:肺移植的阿喀琉斯之踵。
Semin Respir Crit Care Med. 2013 Jun;34(3):336-51. doi: 10.1055/s-0033-1348467. Epub 2013 Jul 2.
5
Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.表型鉴定明确的慢性肺移植物功能障碍可预测肺移植患者体外光化学疗法的反应。
Am J Transplant. 2013 Apr;13(4):911-918. doi: 10.1111/ajt.12155. Epub 2013 Feb 13.
6
Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.肺移植后人类白细胞抗原抗体的意义:441 例患者 10 年的经验。
Chest. 2013 Jul;144(1):226-233. doi: 10.1378/chest.12-0587.
7
Pathologic findings in lung allografts with anti-HLA antibodies.抗 HLA 抗体肺移植的病理解剖发现。
J Heart Lung Transplant. 2013 Mar;32(3):326-32. doi: 10.1016/j.healun.2012.11.018. Epub 2013 Jan 10.
8
Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation.体外膜肺氧合作为肺移植的桥梁。
J Thorac Cardiovasc Surg. 2013 Mar;145(3):862-7; discussion 867-8. doi: 10.1016/j.jtcvs.2012.12.022. Epub 2013 Jan 11.
9
Airway complications post lung transplantation.肺移植术后的气道并发症。
Curr Opin Pulm Med. 2013 Mar;19(2):174-80. doi: 10.1097/MCP.0b013e32835d2ef9.
10
Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.供体特异性抗体与抗体介导的排斥反应、急性细胞排斥反应、移植后支气管闭塞综合征和囊性纤维化有关。
J Heart Lung Transplant. 2013 Jan;32(1):70-7. doi: 10.1016/j.healun.2012.10.007.